Value
6.2/10data confidence 83%| Component | Sub-score |
|---|---|
| P/S | 10.0 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 8.1 |
| PEG | 10.0 |
| Analyst target | 3.0 |
- ▸Forward P/E: 14.8x
- ▸PEG: 0.14
EVH · Why this verdict
Why Evolent Health (EVH) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score4.5/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Quality has breached the engine's minimum floor at 1.6 out of 10 against the 4.0 threshold, with zero recorded ROE, ROA, and margins across the board, triggering an exit recommendation. Warnings | Quality score should remain below the 4.0 floor as long as core profitability metrics stay at zero. | →Stable |
| CounterEvolent has been working through a restructuring and cost-cutting phase in health information services, and temporary margin compression during a turnaround shouldn't be conflated with permanent business impairment. | ||
The stock has already reached and moved past its analyst-target-derived upside, with the model flagging -10.3% versus target and the asymmetry gate failing at -0.69 as a result. Warnings | The asymmetry ratio should stay negative as long as the stock trades above its modeled fair value. | →Stable |
| CounterWith the stock down 53% from its 52-week high already, further re-rating lower could be limited, and any positive catalyst could quickly reopen upside versus a currently depressed target. | ||
The stock is classified as speculative following a steep 53% drawdown from its 52-week high, with the current setup flagged as a recovery: a death cross present but MACD improving. Suitability rationale | MACD improvement should continue and momentum should climb back above the 5.5 gate threshold if the recovery is genuine. | →Stable |
| CounterDeep-drawdown recovery setups can just as easily be brief rebounds within a larger downtrend, especially when the underlying quality score is this weak. | ||
Evolent has split its last 4 quarters evenly between beats and misses, with an average surprise of -38.7%, reflecting an inconsistent earnings track record consistent with the catalyst dimension's earnings concerns. Earnings | The beat/miss ratio should improve toward at least 3 of the next 4 quarters beating estimates. | →Stable |
| CounterA large negative average surprise driven by a couple of severe misses, rather than many small ones, could reflect one-time charges tied to the ongoing business restructuring rather than a structurally deteriorating operating trend. | ||
Short interest stands at an elevated 13% of float, a key risk flagged by the engine, alongside high implied volatility of 97%. Key risks | Short interest should decline below 8% if bearish positioning unwinds. | →Stable |
| CounterElevated short interest combined with a stock already down 53% and showing early recovery signs raises the possibility of a short squeeze, which would work against the bearish thesis rather than confirm it. | ||
Quality has breached the engine's minimum floor at 1.6 out of 10 against the 4.0 threshold, with zero recorded ROE, ROA, and margins across the board, triggering an exit recommendation.
→StableWarnings
- Expectation
- Quality score should remain below the 4.0 floor as long as core profitability metrics stay at zero.
CounterEvolent has been working through a restructuring and cost-cutting phase in health information services, and temporary margin compression during a turnaround shouldn't be conflated with permanent business impairment.
The stock has already reached and moved past its analyst-target-derived upside, with the model flagging -10.3% versus target and the asymmetry gate failing at -0.69 as a result.
→StableWarnings
- Expectation
- The asymmetry ratio should stay negative as long as the stock trades above its modeled fair value.
CounterWith the stock down 53% from its 52-week high already, further re-rating lower could be limited, and any positive catalyst could quickly reopen upside versus a currently depressed target.
The stock is classified as speculative following a steep 53% drawdown from its 52-week high, with the current setup flagged as a recovery: a death cross present but MACD improving.
→StableSuitability rationale
- Expectation
- MACD improvement should continue and momentum should climb back above the 5.5 gate threshold if the recovery is genuine.
CounterDeep-drawdown recovery setups can just as easily be brief rebounds within a larger downtrend, especially when the underlying quality score is this weak.
Evolent has split its last 4 quarters evenly between beats and misses, with an average surprise of -38.7%, reflecting an inconsistent earnings track record consistent with the catalyst dimension's earnings concerns.
→StableEarnings
- Expectation
- The beat/miss ratio should improve toward at least 3 of the next 4 quarters beating estimates.
CounterA large negative average surprise driven by a couple of severe misses, rather than many small ones, could reflect one-time charges tied to the ongoing business restructuring rather than a structurally deteriorating operating trend.
Short interest stands at an elevated 13% of float, a key risk flagged by the engine, alongside high implied volatility of 97%.
→StableKey risks
- Expectation
- Short interest should decline below 8% if bearish positioning unwinds.
CounterElevated short interest combined with a stock already down 53% and showing early recovery signs raises the possibility of a short squeeze, which would work against the bearish thesis rather than confirm it.
TrendMatrix Research · core thesis
Engine thesis — one sentence
Evolent Health is in an early technical recovery from a deep drawdown, but a quality-floor breach, a negative asymmetry gate after already hitting its target, and an inconsistent earnings history keep the setup on exit watch.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
1.6/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 0.0 |
| Op margin | 0.0 |
| Net margin | 0.0 |
| Current ratio | 5.0 |
| Moat | 3.1 |
| Piotroski F | 4.4 |
- ▸No competitive moat
- ▸Quality concerns
Growth
6.5/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 3.1 |
| EPS growth | 10.0 |
Momentum
4.9/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.5 |
| MACD | 7.9 |
| OBV | 1.0 |
| MA position | 8.0 |
| Volume | 3.3 |
- ▸Overbought (RSI 70)
- ▸Volume distribution (falling OBV)
- ▸Above 200-MA but MA slope flat
Sentiment
5.1/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 2.5 |
| Analyst rating | 7.2 |
| Price target | 5.4 |
- ▸LLM news sentiment: -0.50 (n=1)
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.0 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
Peer rank
3.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 9.6 |
| quality rank | 1.3 |
| growth rank | 2.1 |
Technical
2.1/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.1 |
| support resistance | 1.4 |
| 52w position | 0.0 |
| gap | 6.0 |
Risk (lower is worse)
4.0/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 3.4 |
| days to cover | 4.6 |
| volatility | 0.0 |
| put call | 10.0 |
| implied vol | 0.0 |
| max pain risk | 3.0 |
| beta | 8.4 |
| debt equity | 2.5 |
| news risk | 4.0 |
- ▸High IV: 84%
- ▸Above max pain $2
Catalyst
3.4/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 3.5 |
| earnings history | 3.3 |
| earnings timing | 5.0 |
| surprise avg | 0.0 |
| news activity | 5.0 |
- ▸Earnings concerns: 2B/2M
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (7)
- MOMENTUM:4.9>=4.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:31d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- ASYMMETRY:-0.7=NEGATIVE
- DEATH_CROSS:HARD_BLOCK
Warning (1)
- MOMENTUM:4.9<5.5 (soft — BUY_NOW allowed but watch)
Reward-to-Risk
-0.72
Upside
-10.8%
Downside
15.0%
Sizing output
AVOID
SetupRecovery — Death cross but MACD improving, RSI 70
EdgeNo clear edge — No clear edge identified
SuitabilitySpeculative — Drawdown -52% (>40% off 52w high)
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Growth at 6.5 could not lift the engine output above the verdict floor. Failed gate signal: ASYMMETRY:-0.7=NEGATIVE.
The strongest dimensions are Growth at 6.5, Value at 6.2, and Sentiment at 5.1; the weakest are Quality at 1.6, Technical at 2.1, and Peer rank at 3.2. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of -0.72 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Quality Floor Breach
Trip ifQuality score rises above 4.0 from the current 1.6, clearing the floor.
- P2Negative Asymmetry Target Reached
Trip ifAsymmetry ratio rises above 0.5 from the current -0.69.
- P3Deep Drawdown Recovery Setup
Trip ifMomentum score falls below 4.5 from the current 5.4, reversing the recovery.
- P4Inconsistent Earnings History
Trip ifAverage earnings surprise falls below -50% over the next 4 reported quarters.
- P5Elevated Short Interest
Trip ifShort interest rises above 20% of float from the current 13%.